chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Missed dose of the Vaccine; shingles on her face including around the eyes; Shingles, rash, on her face, on her eyebrow near her; Ear bothering her; Persistent headaches; This is a spontaneous report from a contactable consumer. A 41-years-old female patient received first dose of bnt162b2, (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot: number  EN6207), via an unspecified route of administration, administered in Arm Left on 17Mar2021 as 1st dose, single dose for covid-19 immunization. The patient did not had any medical history. Concomitant medication(s) included vitamins nos (MULTIVITAMIN [VITAMINS NOS]) started taking about 5 years ago for good health, prenatal and general women's health vitamin. There was no prior Vaccinations within 4 weeks.On 01Apr2021, in the morning patient experienced persistent headaches, on 03Apr2021, early evening around 5 or 6 PM patient had ear issue started, ear started bothering her the pain started, patient thought she had an ear infection or something. On  06Apr2021, when patient woke up in the morning she had Shingles, rash, on her face, on her eyebrow near her eye. It was reported that patient got first Pfizer covid-19 vaccine injection on 17Mar2021 but then developed shingles 2 weeks later.  She was wondering when she can get second injection, It has been about 7 weeks since the first. She had blisters that opened and then they scabbed. They are not visible but, she can still see what is left of them. It was a week or two ago they started to go away she believes.  She went to Urgent Care and received an antiviral as treatment and was prescribed Valtrex as treatment and she is finished taking Valtrex. The eye doctor she went to see since she had the shingles on her face including around the eyes, told her to wait about 2-3 months to give her body time to heal and her immune system strong again before receiving her second Pfizer covid-19 injection. The patient reported that she needs to make a decision on whether she should get the next dose or not. The outcome of the event ear bothering her was resolved on 10Apr2021, persistent headaches resolved on 14Apr202 and event shingles on her face including, shingles, rash, on her face, on her eyebrow near her resolved on 21Apr2021 and outcome for missed dose of the vaccine was unknown.  No follow-up attempts are needed. No further information is expected.
Shingrix dosing is over six months apart.; This case was reported by a consumer via interactive digital media and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.       Additional Information: GSK Receipt Date: 15-AUG-2022 Reporter's Comments: This case was received from consumer via interactive digital media. The patient received Shingrix dosing was over six months apart. The reporter wanted to knew there any requirement for booster shots. The follow-up could not be possible as no contact details were available. Additional Supportive Information: The patient received 2nd dose of Shingrix later than the recommended interval, which led to lengthening of the vaccine schedule.
12/02/10 - Red facial rash, facial swelling, facial itching. 12/03/10 seen by CFNP Rx - MEDROL dose pack, ZYRTEC or BENADRYL as directed. BENADRYL 25mg given in office.
Temp 104 degrees with seizure. Ambulance was called, transported to ER. Temp down to 101. Released to home. Temp was back up to 102 10/15/11, continued to have some seizure activity. Temp was 100 10/17/11.
Pt. states that after receiving the 1st dose of Moderna 07/29/2021, started experiencing symptoms 07/30/2021 of a rash forming throughout the body. Still continuing to form under the breast and back of the shoulders. No Primary visit noted.
Woke up with medial aspect of right eye sclera hemorrhaged. The bloody look increased throughout the day. but never spread further than medical aspect of right eye. There was no pain, swelling or vision changes. There was no treatment.
about 2.5 hours after vaccination, left arm became very sore - by 2/3 morning arm was painful from the shoulder to the fingertips. next day (4/6) arm remained sore and sensitive to movements until about 7 pm, where it was capable of some movement without extreme pain.  next day (4/6) - woke up about 6 am, slightly nauseous with headache and slightly elevated temperature (99.5 C) by mid-day nausea was gone, but headache and fever had increased to 102 C throughout the day experienced chills, fever, headache, fatigue, and cold sweats went to bed with temp still above 100 C woke up (4/7) and temperature was back to 98.5 C and headache was gone
This spontaneous report as received from a registered pharmacist refers to a 56 years old female patient without any pertinent medical history and with drug reactions/allergic to latex. The patient were vaccinated subcutaneously with a dose of 0.65 ml live ZOSTAVAX (lot# reported as H013944, expired date: 25-OCT-2013) on 05-DEC-2012. There were no concomitant medications. On 06-DEC-2012 the patient developed a rash which was 2 inches wide and 4 inches long around the injection site area. No treatment was given for the AE. The pharmacist noted the patient stated that the rash resolved after a few weeks. There were no lab diagnostics studies performed. The patient did not seek any medical attention. The relatedness between the event and the live ZOSTAVAX was unknown. Additional information is not expected.
Swelling around injection site in shoulder down to elbow. Pain in shoulder, elbow and finger joints. Itchiness, redness on skin. Limited mobility in arm.
Patient began to feel faint after the third immunization(M-M-R) was given. His skin was a little clammy feeling. He called acquaintance to come over and was talking to him. He fainted and then came back to within 20-30 seconds. He remained in the immunization chair. He told her he was feeling a little dizzy and was still talking to her. She held an alcohol swab under his nose. A few minutes later he fainted again and again came back to quickly. At this time, I had EMS (911) called. The patient fainted 1 more time and came back quickly before EMS arrived within 5 minutes of calling them. EMS arrived and put him on a stretcher and took him to the hospital. He was conscious at the time he left. The patients acquaintance came back to the pharmacy at 3PM and stated that the patient had a rash on his arm and was receiving fluids and would be discharged soon.
No adverse effects; one separate dose of an improperly stored vaccine, PEDVAXHIB was administered to one separate patient.; Information has been received from a medical assistant, referring to a patient of unknown age and gender. Information of concomitant therapy, pertinent medical history and drug reactions/allergies was not reported.    On 23-MAY-2019, the patient was vaccinated with improperly stored haemophilus b conjugate vaccine (meningococcal protein conjugate)(LIQUID PEDVAXHIB) 0.5 milliliter (one dose, lot # R013573, expiration date: 22-MAR-2021, frequency was unknown) intramuscularly for prophylaxis (incorrect product storage). No adverse effect was reported.  The vaccines were exposed to temperature of 34.2 Fahrenheit (F) for 4 hour 54 minutes. The temperature excursion was detected by a data logger. No previous excursions were reported. This is one of several reports from the same reporter.; Sender's Comments:  US-009507513-1906USA011674:
Patient presented to the ED due to progressive shortness of breath. Patient was diagnosed with COVID-19 on 3/24/2022 in the outpatient setting. Patient stated that these symptoms were an ongoing issue over the course of the past month. It was noted in the record that the Patient stated a-round the middle of March she did mention to her PCP she was having issues with taste and smell. Patient symptoms became progressively worse and she developed shortness of breath. Patient presented with significant cough, muscle aches in the shoulders, hips and back. No fevers.  The patient was treat for non-Hodgkin?s lymphoma with rituximab the end of February. In the ED the patient was hypoxic at 77% requiring 4 L nasal cannula. Patient?s Labs showed markedly elevated inflammatory markers, elevated proBNP, stable anemia, mild hypokalemia, mildly increased lactic acid. The patient's chest x-ray showed bilateral infiltrates consistent with COVID-19 pneumonia. The patient was given IV steroids and admitted to Hospital for further evaluation and treatment. Chest Xray was Negative for pulmonary embolism and showed interval development of fairly extensive bilateral predominantly ground glass pulmonary opacities. These findings may be inflammatory, secondary to atypical pneumonia, including Covid 19 pneumonia.  The patient was admitted for COVID-19 pneumonia and started on IV steroids. The patient require oxygen and continued to worsen and required progressive increased oxygen requirements. Patient was treated with Lasix without improvement in respiratory status. On 4/1 she was transferred to the ICU due to worsening respiratory failure. The patient required Va potherm and eventually BiPAP. She was given tocilizumab and cefepime for presumed superimposed strep pneumonia, and despite this she continued to worsen. On 4/5, she was BiPAP dependent with significant desaturations with movement. Plan of care was discussed with patient and family. Patient was withdrawn from BiPAP, given comfort focused medications and expired in the ICU on 4/05/2022 at 1343.
pt recv vax 16MAY96 & MAY96 pt devel an itchy rash on feet, torso, arms & legs;rash was described as bites;
Chills, sweats, headache, nausea, body aches...including my hands
CHIEF COMPLAINT:   Pt. arrives via EMS, as per EMS personel pt. was having rectal bleeding today after going to the bathroom. this was witsnessed by her boyfriend, and the blood was trailing from the bathroom to the bedroom. Pt. is also AMS, not answering questions.
A 26-year-old male with no past medical history presents to the emergency department (ED) with an acute episode of chest pain. He reports initially mild dull substernal chest pain for a day prior to an episode of acute sharp chest pain that radiates to his left neck and left shoulder accompanied by diaphoresis leading him to present to the ED. He had received the second dose of the Pfizer-BioNTech mRNA COVID-19 vaccine three days prior to presentation and reported myalgia and weakness beginning within 24 hours of vaccination. His blood pressure on arrival was 126/83 mmHg and pulse was 61 bpm. Electrocardiogram (ECG) on admission showed diffuse upsloping 2mm STE, no reciprocal changes, and PR elevation in aVR. Troponin-I on admission was 6.03 ng/ml prior to peaking at 21 ng/ml while initial CRP was 56.8 mg/L. Transthoracic echo (TTE) showed left ventricular ejection fraction (LVEF) of 55-60% with hypokinesis of the basal lateral wall. Cardiac magnetic resonance imaging (CMR) was consistent with myocarditis showing subepicardial late gadolinium enhancement (LGE) in the basal inferior wall, no edema on T2 sequences, and a mildly reduced left ventricular systolic function with an LVEF of 51%. He was started on colchicine, low dose beta blocker and losartan and improved symptomatically along with resolution of the EKG findings prior to being discharged with plan for close outpatient follow-up and repeat imaging.  In addition, a respiratory viral PCR panel was obtained which was positive for Rhinovirus/Enterovirus on nasal swab. Although it is possible that his presentation was secondary to enteroviral myocarditis, the temporal relationship to the second dose of Pfizer-BioNTech mRNA COVID-19 vaccine suggests the possibility of myocarditis secondary to immunologic response to COVID-19 vaccine itself.
Swelling of nodes under left arm, soreness under arm spreading to breast, low grade fever, scratchy throat, muscle aches and sinus symptons.
shingles; Information has been received from a lawyer regarding a case in litigation referring to currently 86-year-old patient (pt) of unknown gender. The pt's pertinent medical history, concurrent conditions and concomitant medications were not provided. On or about 21-JAN-2013, the pt was vaccinated with zoster vaccine live (ZOSTAVAX) for the long-term prevention of shingles and zoster-related conditions (route of administration was unknown and strength, dose, anatomical location, lot # and expiration date were not reported). On an unknown date, reported as subsequently, pt was treated by a physician and a physician assistant, at a local medical center, for shingles (herpes zoster) which resulted from zoster vaccine live (ZOSTAVAX) use. At reporting time, the outcome of herpes zoster was unknown
This spontaneous report as received from a other health professional refers to a three patients of unknown age. On an unknown date the patients were vaccinated with PROQUAD lot # M042501 for prophylaxis. Concomitant therapies included sterile diluent. On an unknown date the patients experienced incorrect product storage and no adverse event. The outcome of incorrect product storage and no adverse event is unknown. The reporter considered incorrect product storage and no adverse event to be not related to PROQUAD. This is one of two reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1708USA005227.
Pt reports he developed dizziness, lightheadedness, and general body aches after getting his vaccines.
Tiredness, out of breath after a few normal activities.  Five days later cold/sinus symptoms started with a sore throat, severe dryness of throat, nose, then congestion, runny nose, chills, NEVER a fever. A week later still tire, a little congestion, cough, some white liquid flem.
Within 3 hours of getting the vaccine, I noticed red, swollen hives on both forearms. It was very itchy and uncomfortable. I also got hives on the bottom of my neck. I noticed slight difficulty in breathing, but it was not significant enough to require emergency care. The hives persisted overnight and showed up on both hands as well. The hives on my arms lasted about 4 days. The hives on my hands lasted about 6 days and are  only slightly itchy now. The hives are still on my neck and now under my eyes and throughout my face/jawline (1 week after vaccination).
Two days after Twinrix shot client woke up and feet began to be tingly, Left arm to fingers tingled and numb left side of face, feels weak, Left eye dry twitching and H/A left frontal lobe and in back of head pt to own Drs. MRI done and labwork done.
Patient was given the second dose of Pfizer Covid 19 vaccine on 6/2/21 at 12:29pm and was asked to wait for 15 minutes to watch how the patient reacts with the vaccine. He didn't have any side effect on his first dose. After 3 minutes of getting the vaccine, his wife notified me that she needs assistance. He was sweating profusely and was about to lose consciousness. His wife and I kept saying his name to check his response. He could not response or was about to faint. His pulse is slow, and his face is red. Since there was other customers waiting for shots in the clinic, I asked the technician to ask for pharmacy manager assistance. He came in the clinic, and checked patient's pulse and blood pressure. The blood pressure was high (170/89). We checked his blood pressure again, and it was lower after couple minutes. Patient started to have consciousness and understand what we are talking. He told us that he always had the same reaction after getting his blood drawn. We asked him to sit down and was monitored by us in the clinic. After 30 minutes, he said that he was feeling fine without any problems and decided to leave. He can breathe ok and didn't have any adverse reactions such as swelling of throat and lip or hives. His wife and he didn't eat anything before getting the vaccine. I checked his blood pressure again, and it was 130/80. Will follow up on him this evening and tomorrow.
Received Td 10/29/2003.  No fever, normal tenderness next day.  1 week post injection developed tremor left arm - more noticeable in hand.  Saw PMD with diagnosis of bilateral muscle reaction.  Had one dose and low dose Valium.  Tremor ceased 11/11/2003.
Husband was hospitalized for cardiac problems. I went to pick him up - I collapsed in excruciating pain behind the wheel - I couldn't sit up to drive - had severe trouble breathing - pain was all around waist & middle of back - had to go to ER - collapsed on the floor.
Perimyocarditis requiring hospitalization. Treatment with colchicine and ibuprofen. Hemodynamically stable and discharged after a day of monitoring. Presented due to refractory chest pain originally.
11-22-05 Telephone call from pt, c/o sore and reddened arm at site of injection. Chills and fever (mo/thermometer). 12-02-05 Spoke with pt as  follow-up. Had "chills and fever" for several days. Also c/o headache, right arm red and swollen from elbow to shoulder. Used Ibuprofen and Benadryl (pm). Symptoms lasted about 1 week. Now injection area itchy and small hard spot at injection site.
This case was reported by a physician via call center representative and described the occurrence of Injection site tenderness in a elderly female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, unknown after receiving SHINGRIX, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown. Additional details were reported as follows: The age at vaccination was not reported. The physician stated his wife was late for the second dose of the SHINGRIX series, which led to lengthening of the vaccination schedule. Follow up information received from physician on 11th February 2019: The patient's demographic details were updated. The VAERS details were updated. This was an inquiry about receiving SHINGRIX vaccine 2nd dose late, complicated by need for surgery when vaccine finally available creating the question. The reporter asked it's safe to take SHINGRIX vaccine post operatively. The patient did well after surgery and had access to SHINGRIX. The reporter stated that the patient decided to get the 2nd dose at 3 weeks post-op. However, she developed a UTI the day of vaccination, which caused me to call GlaxoSmithKline for guidance with receiving the vaccine in lieu of an illness. The discussion lead to a decision that the urinary tract infection was a minor illness like a cold and there was no contraindication to receiving the SHINGRIX. The patient had her 2nd SHINGRIX dose on 30th January 2019 exactly 3 weeks post-operation. Within 24hrs, she experienced tenderness, but no swelling or erythema at the injection site. She also felt minor malaise, loss of energy, stayed in bed for 24hrs. She never had any fever, chills, nausea or vomiting. By 2nd day post vaccination she was better and the urinary tract infection had improved but not completely resolved. The reporter mentioned, her urinary tract infection was lower tract cystitis, with dysuria, and frequency. She started OTC Pyridium initially and within 24hrs. added antibiotic- MACROBID 100mg, bid x 5 days. The urinary tract infection abated in 24hrs of starting antibiotic and completely resolved within the 5 days.
Pain on the left side; Lump; Painful to eat; A spontaneous case was received from the consumer concerning female patient of unknown age who received Moderna's COVID-19 vaccine and experienced pain on the left side, lump and painful to eat.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 26-Jan-2021 prior to the onset of the events, the patient received first of the two planned doses of mRNA-1273 for the prophylaxis of COVID-19 infection.  On 27-Jan-2021 the patient experienced she had pain on the left side from her neck, mouth, and ear. She felt like there was a lump. It has been very painful to eat. Treatment of the event was not provided.  Action taken with the second dose of mRNA-1273 in response to the event was not reported.  The outcome of the events, pain on the left side, lump and painful to eat was not resolved.
Local redness, induration up progression of swelling into supraclaviculr area and lateral muscle with feeling fatigued on  and off. L infection vs. allergic. Rec'd on 2/23/04 of Dicloxicellou and Zyrtec.
Redness, itching and mild swelling developed around the injection site one week after first vaccination.
Patient developed cellulitis at injection site. Treated with clindamycin and cephalexin x 7 days.
Received vaccine 5/11. 5/13 left arm pain starting at inner upper arm and radiating to lower wrist. Noted increasing pain with stretching and range of motion. Denies wound, erythema, drainage at injection site. Denies weakness, numbness, tingling, skin changes to left arm. Describes pain and sharp and "pulling".  OTC Advil taken for treatment with mild improvement. Pain has progressively worsened over the last 4 days.
I developed a very large painful bruise on my opposite side flank within 48 hours of the vaccine. Bruise is nowhere near the injections site.
Heart Racing, palpitations, nausea, vomiting, headache, pain that moved from one location to another, body tremors, muscle pain, muscle contractions, muscle spasms, dizziness, lightheaded, anxiety, numbness in tongue, brain fog, brain zaps, muscle weakness, fatigue, chest pain, ringing in ears, joint pain, twitching, internal vibrations, left upper quadrant pain , right abdominal pain, flushing, sensitivity to light, extreme dehydration, difficult swallowing.
Pt received vaccine on 10/12/10 on 10/13/10 pt's husband called with concern that area inflamed (hot and red) and spreading. Pt advised to see MD. MD determined it was cellulitis. Pt received pneumococcal vaccine in the inflamed area (left deltoid).
This patient received her first dose of Moderna vaccine and was then sent to the observation area. Within 10 minutes of vaccine receipt, she began complaining of a fast heart beat and some tightness in the throat. Emergency services was called immediately and she was placed supine in a stretcher. Her initial vitals were: heart rate of 130 beats/minute and oxygen saturation of 95%. Repeated vitals were as follows: 11:25- BP 162/94,HR 123, SO2- 98% 11:30- BP 161/81 HR 101, SO2- 96% 11:35- BP 160/106 HR 95, SO2- 96% 11:35 - BP 157/96 HR 96, SO2- 95%  complaining of tingling in fingers. 11:40- BP 162/79 HR 91, SO2- 96%  11:45- BP 152/84HR 92, SO2- 95% denies chest pain, shortness of breath, or throat tightness at this time.   Patient felt better within 20 minutes and was taken to the emergency department for evaluation. In the emergency department, she was encouraged to obtain the remainder of the work up but declined and elected to go home. She denied rashes, respiratory distress, or itching at the time of discharge from the emergence department. She planned to follow up with her outpatient primary care provider.
Gradually became more flu-like ill  from 8/7/21-8/13/21; extremely fatigued 8/14/21  and difficulty being coherent; ambulance called approx. 1 am 8/15/21 due to inability to walk, extreme shaking, and not able to identify where he was or his name.  Immediately hospitalized, confused, CT, Tests, seizure in ER, incubated, and medicated into sleep state for own well being.  Spent weeks in ICU running tests and researching like symptoms.  Diagnosed with Encephalitis,  reaction to Covid-19 vaccine.  Released 8/27/2021 to home-care from hospital with walker, extreme cognitive and physical deficits.  Admitted to  intensive therapy treatment program in October 2021 to current.  Has regained some cognitive and physical ability.  Lost hearing and had eye surgery all related to original onset of encephalitis.  Remains under doctors care and treatments for recovery.